Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice.
Recent evidence indicates that toll-like receptor (TLR) 2 and 4 are involved in the pathogenesis of dilated cardiomyopathy (DCM), but the exact mechanisms of their actions have not been elucidated. We explored the therapeutic potential of blocking TLRs in mice with established cardiomyopathy. Cardio...
Enregistré dans:
Auteurs principaux: | Yonggang Ma, Xiaowei Zhang, Huayan Bao, Su Mi, Wenfeng Cai, Huimin Yan, Qingqing Wang, Ziyan Wang, Jun Yan, Guo-Chang Fan, Merry L Lindsey, Zhuowei Hu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/57bd32d6ad9c48acab6e47ee9176c79a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease.
par: Simona E Budulac, et autres
Publié: (2012) -
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
par: Amani E. Khalifa, PhD, et autres
Publié: (2021) -
The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes.
par: Philippe Georgel, et autres
Publié: (2009) -
Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.
par: Katja Derkow, et autres
Publié: (2013) -
TLR2 and TLR4 in Parkinson’s disease pathogenesis: the environment takes a toll on the gut
par: Anastazja M. Gorecki, et autres
Publié: (2021)